Physician profile
Avery Eriksson
NPI 1780194530
$6,217.09
in general payments reported to CMS, 2019-2025
39 companies · $1,478 in 2025
The $1,478 reported for 2025 was more than what 89% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $324 · 2022: $1,211 · 2023: $1,719 · 2024: $1,486 · 2025: $1,478.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,683.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,682.74 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $951.89 | 2021-2025 | |
| Pfizer INC. | $852.91 | 2023-2025 | |
| Astrazeneca Pharmaceuticals LP | $698.89 | 2022-2025 | Farxiga, Airsupra, Breztri |
| Novo Nordisk INC | $684.85 | 2021-2025 | Ozempic, Rybelsus, Wegovy |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $414.13 | 2021-2025 | Xifaxan |
| Glaxosmithkline, LLC. | $309.48 | 2021-2025 | Trelegy Ellipta, Arexvy |
| Bayer Healthcare Pharmaceuticals INC. | $206.97 | 2022-2024 | |
| Lilly USA, LLC | $196.17 | 2021-2025 | Mounjaro, Zepbound, Jardiance |
| Amgen INC. | $180.04 | 2022-2025 | Evenity, Repatha, Otezla |
| Astellas Pharma US INC | $170.47 | 2024-2025 | Veozah |
| Boehringer Ingelheim Pharmaceuticals, INC. | $154.30 | 2021-2025 | Jardiance |
| Xeris Pharmaceuticals, INC. | $154.21 | 2022-2025 | Keveyis, Gvoke Hypopen |
| Janssen Pharmaceuticals, INC | $141.07 | 2022-2025 | Spravato, Xarelto |
| Exact Sciences Corporation | $93.56 | 2023-2025 | Cologuard Collection Kit |
| Otsuka America Pharmaceutical, INC. | $87.64 | 2023-2025 | Rexulti |
Show all 39 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Avery Eriksson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.